TY - JOUR
T1 - The metabolic syndrome and cardiovascular disease
T2 - Part I
AU - Jiamsripong, Panupong
AU - Mookadam, Martina
AU - Honda, Tadaaki
AU - Khandheria, Bijoy K.
AU - Mookadam, Farouk
PY - 2008
Y1 - 2008
N2 - The metabolic syndrome is a constellation of metabolic risk factors and physical conditions that are accompanied by an enhanced propensity toward the development of type 2 diabetes, atherosclerosis, and cardiovascular disease. It presents a combination of atherosclerosis risk including atherogenic dyslipidemia, hypertension, elevated plasma glucose, hypercoagulability, and a proinflammatory state. The 2 major underlying risk factors for the metabolic syndrome are obesity and insulin resistance. Exacerbating factors are physical inactivity, advancing age, and endocrine and genetic factors. Associated hyperinsulinemia, hyperglycemia, and elevated adipokine levels (adipose cytokines) lead to vascular endothelial dysfunction, an abnormal lipid profile, hypertension, and vascular inflammation, all of which promote the development of atherosclerotic cardiovascular disease. In this 2-part series, the authors present an up-to-date and detailed systematic review of the literature on this important topic.
AB - The metabolic syndrome is a constellation of metabolic risk factors and physical conditions that are accompanied by an enhanced propensity toward the development of type 2 diabetes, atherosclerosis, and cardiovascular disease. It presents a combination of atherosclerosis risk including atherogenic dyslipidemia, hypertension, elevated plasma glucose, hypercoagulability, and a proinflammatory state. The 2 major underlying risk factors for the metabolic syndrome are obesity and insulin resistance. Exacerbating factors are physical inactivity, advancing age, and endocrine and genetic factors. Associated hyperinsulinemia, hyperglycemia, and elevated adipokine levels (adipose cytokines) lead to vascular endothelial dysfunction, an abnormal lipid profile, hypertension, and vascular inflammation, all of which promote the development of atherosclerotic cardiovascular disease. In this 2-part series, the authors present an up-to-date and detailed systematic review of the literature on this important topic.
UR - http://www.scopus.com/inward/record.url?scp=50549097317&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=50549097317&partnerID=8YFLogxK
U2 - 10.1111/j.1751-7141.2008.07809.x
DO - 10.1111/j.1751-7141.2008.07809.x
M3 - Review article
C2 - 18607151
AN - SCOPUS:50549097317
SN - 1520-037X
VL - 11
SP - 155
EP - 161
JO - Preventive Cardiology
JF - Preventive Cardiology
IS - 3
ER -